Guaifenesin Tablet, Extended Release
Product Images NDC 79903-124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 79903-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walmart Stores, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 Extended-Release Tablet Blister Pack Carton)

Principal Display Panel (20 Extended-Release Tablet Blister Pack Carton)
This is a drug facts label for Guaifenesin Extended-Release Tablets, 600mg, an expectorant that helps in loosening phlegm (mucus) and thin bronchial secretions. It is used to relieve chest congestion and make coughs more productive. The active ingredient in each tablet is Guaifenesin, USP 600 mg. It contains directions to take one or two tablets every 12 hours, and consumers are cautioned not to exceed 4 extended-release tablets in 24 hours. This medication should not be used for children under 12 years of age or if the person is pregnant or breastfeeding, among other special considerations. It is distributed by Walmart Inc., Bentonville, AR.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.